全球伴侣动物疫苗市场规模、份额、趋势和成长分析报告（2026-2034）

预计到 2034 年，伴侣动物疫苗市场规模将达到 67.3 亿美元，高于 2025 年的 36.4 亿美元，预计从 2026 年到 2034 年的复合年增长率将达到 7.06%。

受宠物饲养量增加和动物健康意识提升的推动，全球伴侣动物疫苗市场正经历强劲成长。疫苗在预防犬猫等宠物感染疾病发挥着至关重要的作用，有助于延长宠物的寿命并提高其健康水平。宠物「人性化」以及宠物饲主日益增长的医疗保健投入意愿，正显着推动已开发地区和新兴市场市场的扩张。

成长要素包括兽医生物技术的进步、动物医院就诊量的增加以及宠物保险覆盖范围的扩大。各国政府和兽医组织也积极推广疫苗接种计划，以控制通用感染疾病。此外，先进疫苗和联合疫苗的研发也促进了市场成长，这些疫苗提高了疫苗的有效性，并减少了所需的接种次数。

随着新疫苗研发的进展和接种方法的改进，市场预计将进一步受益。 DNA疫苗和mRNA疫苗等技术创新正吸引人们的注意。随着宠物照护在全球家庭中日益受到重视，伴侣动物疫苗市场预计将持续强劲成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球伴侣动物疫苗市场：依疫苗类型划分

• 市场分析、洞察与预测
• 减毒活病毒疫苗
• 结合疫苗
• 灭活疫苗
• DNA疫苗
• 重组疫苗
• 其他疫苗类型

第五章 全球伴侣动物疫苗市场：依动物类型划分

• 市场分析、洞察与预测
• 狗
• 猫
• 马
• 鸟类

第六章 全球伴侣动物疫苗市场：依给药途径划分

• 市场分析、洞察与预测
• 肠外
• 口服
• 鼻腔

第七章 全球伴侣动物疫苗市场：依通路划分

• 市场分析、洞察与预测
• 兽药
• 零售药房
• 电子商务

第八章 全球伴侣动物疫苗市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Zoetis
  • Merck Animal Health
  • Boehringer Ingelheim
  • Elanco Animal Health
  • Virbac
  • Ceva Sante Animale
  • Vetoquinol
  • HIPRA
  • Biogenesis Bago
  • Bioveta
  • Indian Immunologicals
  • Brilliant Bio Pharma
  • Durvet
  • Sinovac

The Companion Animal Vaccines Market size is expected to reach USD 6.73 Billion in 2034 from USD 3.64 Billion (2025) growing at a CAGR of 7.06% during 2026-2034.

The global companion animal vaccines market is experiencing strong growth due to increasing pet ownership and rising awareness of animal health. Vaccines play a crucial role in preventing infectious diseases in pets such as dogs and cats, ensuring longer and healthier lives. The humanization of pets and the growing willingness of owners to invest in preventive healthcare are significantly driving market expansion across both developed and emerging regions.

Key drivers include advancements in veterinary biotechnology, increasing veterinary visits, and expanding pet insurance coverage. Governments and veterinary organizations are also promoting vaccination programs to control zoonotic diseases. Additionally, the development of advanced and combination vaccines is improving efficiency and reducing the number of doses required, further supporting market growth.

Looking ahead, the market is expected to benefit from ongoing research into novel vaccines and improved delivery methods. Technological innovations such as DNA vaccines and mRNA-based solutions are gaining attention. As pet care continues to evolve into a priority for households worldwide, the companion animal vaccines market is poised for sustained and robust growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Vaccine Type

• Attenuated Live Vaccine
• Conjugate Vaccine
• Inactivated Vaccine
• Dna Vaccine
• Recombinant Vaccine
• Other Vaccine Types

By Animal Type

• Canine
• Feline
• Equine
• Avian

By Route Of Administration

• Parenteral
• Oral
• Nasal

By Distribution Channel

• Veterinary Hospital Pharmacies
• Retail Pharmacies
• E-Commerce

COMPANIES PROFILED

• Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco Animal Health, Virbac, Ceva Sant Animale, Vetoquinol, HIPRA, Biogenesis Bag, Bioveta, Indian Immunologicals, Brilliant Bio Pharma, Durvet, Sinovac
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL COMPANION ANIMAL VACCINES MARKET: BY VACCINE TYPE 2022-2034 (USD MN and Million Doses)

• 4.1. Market Analysis, Insights and Forecast Vaccine Type
• 4.2. Attenuated Live Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 4.3. Conjugate Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 4.4. Inactivated Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 4.5. Dna Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 4.6. Recombinant Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 4.7. Other Vaccine Types Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 5. GLOBAL COMPANION ANIMAL VACCINES MARKET: BY ANIMAL TYPE 2022-2034 (USD MN and Million Doses)

• 5.1. Market Analysis, Insights and Forecast Animal Type
• 5.2. Canine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 5.3. Feline Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 5.4. Equine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 5.5. Avian Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 6. GLOBAL COMPANION ANIMAL VACCINES MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN and Million Doses)

• 6.1. Market Analysis, Insights and Forecast Route Of Administration
• 6.2. Parenteral Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 6.3. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 6.4. Nasal Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 7. GLOBAL COMPANION ANIMAL VACCINES MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN and Million Doses)

• 7.1. Market Analysis, Insights and Forecast Distribution Channel
• 7.2. Veterinary Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 7.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 7.4. E-Commerce Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 8. GLOBAL COMPANION ANIMAL VACCINES MARKET: BY REGION 2022-2034 (USD MN and Million Doses)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 8.2.1 By Vaccine Type
  • 8.2.2 By Animal Type
  • 8.2.3 By Route Of Administration
  • 8.2.4 By Distribution Channel
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 8.3.1 By Vaccine Type
  • 8.3.2 By Animal Type
  • 8.3.3 By Route Of Administration
  • 8.3.4 By Distribution Channel
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 8.4.1 By Vaccine Type
  • 8.4.2 By Animal Type
  • 8.4.3 By Route Of Administration
  • 8.4.4 By Distribution Channel
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 8.5.1 By Vaccine Type
  • 8.5.2 By Animal Type
  • 8.5.3 By Route Of Administration
  • 8.5.4 By Distribution Channel
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 8.6.1 By Vaccine Type
  • 8.6.2 By Animal Type
  • 8.6.3 By Route Of Administration
  • 8.6.4 By Distribution Channel
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL COMPANION ANIMAL VACCINES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Zoetis
  • 10.2.2 Merck Animal Health
  • 10.2.3 Boehringer Ingelheim
  • 10.2.4 Elanco Animal Health
  • 10.2.5 Virbac
  • 10.2.6 Ceva Sante Animale
  • 10.2.7 Vetoquinol
  • 10.2.8 HIPRA
  • 10.2.9 Biogenesis Bago
  • 10.2.10 Bioveta
  • 10.2.11 Indian Immunologicals
  • 10.2.12 Brilliant Bio Pharma
  • 10.2.13 Durvet
  • 10.2.14 Sinovac